MoneyWorks4Me

Smruthi Organics - Quaterly Results

06 Aug 2022 Evaluate
A decrease in the sales to Rs. 290.73 millions was observed for the quarter ended June 2022. The sales stood at Rs. 308.96 millions during the similar quarter previous year.Net Profit for the quarter ended June 2022 dipped to Rs. 3.04  millions from Rs. 25.33 millions  in the corresponding previous quarter.A decline of 17.47 millions was observed in the OP in the quarter ended June 2022 from 46.18 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 290.73 308.96 -5.90 290.73 308.96 -5.90 1333.72 1265.01 5.43
Other Income 0.31 1.81 -82.87 0.31 1.81 -82.87 5.83 5.61 3.92
PBIDT 17.47 46.18 -62.17 17.47 46.18 -62.17 190.12 290.95 -34.66
Interest 1.19 2.27 -47.58 1.19 2.27 -47.58 9.84 10.93 -9.97
PBDT 16.28 43.91 -62.92 16.28 43.91 -62.92 180.28 280.02 -35.62
Depreciation 11.15 10.50 6.19 11.15 10.50 6.19 42.56 39.46 7.86
PBT 5.13 33.41 -84.65 5.13 33.41 -84.65 137.72 240.56 -42.75
TAX 2.09 8.08 -74.13 2.09 8.08 -74.13 33.90 69.48 -51.21
Deferred Tax -0.13 -0.24 -45.83 -0.13 -0.24 -45.83 -1.70 1.42 -219.72
PAT 3.04 25.33 -88.00 3.04 25.33 -88.00 103.82 171.08 -39.31
Equity 114.46 114.46 0.00 114.46 114.46 0.00 114.46 114.46 0.00
PBIDTM(%) 6.01 14.95 -59.80 6.01 14.95 -59.80 14.25 23.00 -38.02
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..